ALSTON PHARMACY LIMITED

💤Zombieactive
07362183 · ltd · incorporated 2010-09-01
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Mar 2025
Net worth
book net assets
Opportunity
77/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Other human health activities
Sector: Human health & social work
Investor take
Pursue
Strong opportunity: active trading company with strong profile and bankable structure.

Opportunity 77/100 (strong), bankability 80/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Discharge stale live charges. 1 live charge(s) created 15+ years ago — likely paid but undischarged. Clean register. Most likely exit: strategic trade sale (65/100).

🏦

Refinance opportunity

1 live charge · oldest 15.2y

45/100
under pressure

Refinance would be pressure-driven, not opportunity-driven. Expect tighter margins and covenant scrutiny.

  • · Oldest live charge is 15.2 years old — likely at or near maturity.
  • · Single lender — cleanest path to refinance.
  • · Distress signals active — lender appetite narrows.

Data confidence

Overall: medium (77/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
1 charges (1/1 with lender, 1/1 with type)
90
Directors & officers
3 officers (1 active, 3 linked, 2 with DOB)
83
Ownership & PSC
1 active PSC(s) of 2 total, 2 with control declared
90
Director network
Network not yet resolved
30
Filing history
42 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
77/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
60
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
100
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£20k£39k£59k£78k£98kMar 2024Mar 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2025-03-312024-03-31
Total assets£39.7k
Current assets£97.5k
Net assets£26.2k
Average employees3

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
1
filing
  • 1 persons-with-significant-control
Last 180 days
1
filing
  • 1 persons-with-significant-control
Counts from Companies House filing history.
Corporate timeline (22 events)Click to expand
  1. 2026-03-25
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  2. 2025-11-20
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  3. 2024-12-09
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  4. 2023-11-24
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  5. 2022-12-22
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  6. 2021-12-20
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  7. 2021-03-31
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  8. 2019-11-15
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  9. 2018-12-23
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  10. 2017-12-22
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  11. 2017-09-14
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  12. 2017-09-14
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  13. 2017-03-03
    📄
    resolution
    resolution · RESOLUTIONS
  14. 2017-01-11
    📄
    change-person-director-company-with-change-date
    officers · CH01
  15. 2016-12-23
    📄
    accounts-with-accounts-type-total-exemption-small
    accounts · AA
  16. 2012-03-23
    CHAMBERS, Mary resigned
    secretary
  17. 2012-03-23
    CHAMBERS, Mary resigned
    director
  18. 2011-03-15
    🔒
    Charge registered #1
    Lender: Santander UK PLC (Santander)
  19. 2010-09-01
    🏢
    Company incorporated
    As ALSTON PHARMACY LIMITED
  20. 2010-09-01
    MAGUIRE, Conor appointed
    director
  21. 2010-09-01
    CHAMBERS, Mary appointed
    secretary
  22. 2010-09-01
    CHAMBERS, Mary appointed
    director

Owner dependency

85/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Long-tenure founder: Senior director has been in place 16 years — deep operational knowledge concentrated in one person.

Succession & seller-readiness

68/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
  • secondary12+ year tenure: Director in role 16 years.
  • secondaryStable-but-static management: Company is 16 years old and no new directors in the last 3 years — succession not yet being planned internally.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Mr Conor Maguire
Individual · British · DOB 12/1978 · age 48
75100%
75–100%75-100% shares · 75-100% voting06/04/2016
1 historic (ceased) PSC
  • Philip James Chambersceased 13/12/2016· 25-50% shares · 25-50% voting

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · CA postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
121 CARE AGENCY LIMITED
15657669 · est 2024 · no financials extracted
1y
A&C STANLEY LTD
13002990 · est 2020 · no financials extracted
5y
AB&DG SERVICES LIMITED
11603769 · est 2018 · no financials extracted
7y
ABSHA LIMITED
14644931 · est 2023 · no financials extracted
3y
ACTIVE MEDICAL LIMITED
04432916 · est 2002 · no financials extracted
23y
ACTIVELIFE MEDIC-CARE UK LTD
14071631 · est 2022 · no financials extracted
3y
ADSTAPHIMED LIMITED
14024628 · est 2022 · no financials extracted
4y
ADVANCED AESTHETICS DR EWELINA EMILIANOWICZ LTD
15562826 · est 2024 · no financials extracted
2y
ALL SEASONS HOME CARE (CARLISLE) LIMITED
07347506 · est 2010 · no financials extracted
15y
AMIDENT LIMITED
14477432 · est 2022 · no financials extracted
3y
AMIT PAIK LTD
13138624 · est 2021 · no financials extracted
5y
AMS ST HELENS LIMITED
11761082 · est 2019 · no financials extracted
7y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2010-09-01
Jurisdictionengland-wales
Primary SIC86900 — Other human health activities

Registered office

Alston Pharmacy
Front Street
Alston
Cumbria
CA9 3QP

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2026-09-29
Last: 2025-09-15

Officers (1 active · 2 resigned)

MAGUIRE, Conor
director · ~48y · appointed 2010-09-01
View their other companies + combined net worth →
Active
CHAMBERS, Mary
secretary · appointed 2010-09-01 · resigned 2012-03-23
Resigned
CHAMBERS, Mary
director · ~67y · appointed 2010-09-01 · resigned 2012-03-23
Resigned

Click a director name to see their full track record across all companies.

Mortgages & charges

1
Total charges
1
Outstanding
1
Active lenders
Status:Lender:1 of 1 shown
TypeProperties
outstanding
Santander
Santander UK PLC (Santander)
Legal and general charge1 property15/03/2011
Click column headers to sort. Use filters above to narrow by status and lender.

Recent filings (42 total)

change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2026-03-25
accounts-with-accounts-type-micro-entity
accounts · AA
2025-11-20
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-09-18
accounts-with-accounts-type-micro-entity
accounts · AA
2024-12-09
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-09-19
accounts-with-accounts-type-micro-entity
accounts · AA
2023-11-24
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-09-18
accounts-with-accounts-type-micro-entity
accounts · AA
2022-12-22
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-09-16
accounts-with-accounts-type-micro-entity
accounts · AA
2021-12-20
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-09-16
accounts-with-accounts-type-micro-entity
accounts · AA
2021-03-31
confirmation-statement-with-no-updates
confirmation-statement · CS01
2020-09-21
accounts-with-accounts-type-micro-entity
accounts · AA
2019-11-15
confirmation-statement-with-no-updates
confirmation-statement · CS01
2019-08-19